NAGE Earnings Date: Nov 4, 2026 (Estimated) — Niagen Bioscience Inc
NASDAQ · Healthcare · Biotechnology
Updated
When is NAGE's next earnings date?
Niagen Bioscience Inc (NAGE) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.01 on revenue of $33.7M.
How did NAGE do in its last earnings report?
In its most recent report on Aug 4, 2026 (Q2 2026), Niagen Bioscience Inc posted EPS of $0.01 versus the $0.02 estimate, a miss of 50.0%. Revenue was $29.8M against a $31.4M estimate. The stock's 1-day post-earnings move was -14.7%.
How much does NAGE stock move after earnings?
NAGE beat EPS estimates in 7 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 20.9% (up or down) in the day after earnings.
About Niagen Bioscience Inc
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | Q2 2026 | 0.02 | 0.01 | -50.00% | $29.8M | ❌ Miss | -14.70% | -11.24% | -8.65% |
| 2026-05-06 | Q1 2026 | 0.06 | 0.07 | +16.67% | $31.5M | ✅ Beat | -15.69% | -24.35% | -30.58% |
| 2026-03-04 | Q4 2025 | 0.01 | 0.03 | +200.00% | $33.8M | ✅ Beat | +3.24% | -1.01% | -11.34% |
| 2025-11-04 | Q3 2025 | 0.01 | 0.05 | +400.00% | $34.0M | ✅ Beat | -1.01% | +3.02% | -3.60% |
| 2025-08-06 | Q2 2025 | 0.01 | 0.04 | +300.00% | $31.1M | ✅ Beat | +2.23% | +7.66% | +0.32% |
| 2025-03-04 | Q4 2024 | 0.02 | 0.09 | +350.00% | $29.1M | ✅ Beat | +52.68% | +41.07% | +26.43% |
| 2024-10-31 | Q3 2024 | 0.00 | 0.02 | +100.00% | $25.6M | ✅ Beat | +67.91% | +93.98% | +116.62% |
| 2024-08-07 | Q2 2024 | -0.02 | 0.00 | +100.00% | $22.7M | ✅ Beat | +9.51% | +14.83% | +26.62% |
Showing last 8 quarters.